semaglutide and losartan FDA expands recall—again Losartan is often given quietly

Lower, customized dosages allow providers to closely monitor patients responses, reduce the likelihood of adverse effects, and tailor treatment to each patient's particular medical needs

Nutritional deficiencies may develop during GLP-1 treatment, particularly when appetite suppression leads to inadequate dietary intake

Oral and topical glutathione are generally well tolerated in studies and appear to be safe at typical doses, although long-term data are limited

Open research questions Important unanswered questions remain: the longterm cardiovascular implications of supplementrelated TMAO rises, optimal doseresponse in different age groups and sexes, and whether specific probiotics or conutrients can reduce gut conversion of carnitine to TMAO while preserving benefits